Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection

Eli Zuckerman(Carmel (Israel)), Elias Toubi(Bnai Zion Medical Center), K HALAS(Bnai Zion Medical Center), Gleb Slobodin(Bnai Zion Medical Center), Aharon Kessel(Technion – Israel Institute of Technology), Edmond Sabo(Carmel Medical Center), Daniel Yeshurun
Clinical & Experimental Immunology
May 1, 2002
10.1046/j.1365-2249.2002.01844.x
Cited by 55

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Allergy|2014|1.2k
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Dermatology Review|2015|428
Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression
|Clinical Cancer Research|2006|360